Archives

by in
Entry Author Date Location
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital 03/17/15 National
Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow 03/16/15 Texas
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug 03/12/15 San Diego
Music As Therapy? PureTech’s “Sync Project” Aims to Prove It 03/11/15 Boston
In Oncology Shuffle, Amgen To Shutter Onyx, Lay Off About 300 03/10/15 San Francisco
Hope to See You Thursday at “New York’s Life Science Disruptors” 03/10/15 New York
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
CTI Goes Up, And Down, And Back Up On Phase 3 Myelofibrosis News 03/09/15 Seattle
Arrowhead’s Novartis RNAi Deal: Big Boost or ‘Stale Potato Chips’? 03/09/15 Wisconsin
NIH Director Hails “Stunning Case” as Example of Genomic Revolution 03/06/15 San Diego
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Early VC Arch Exits Ikaria with $2.3B Sale to Mallinckrodt 03/05/15 New York
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” 03/04/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Just Eight Days Left—Get Your Seat for “New York’s Life Science Disruptors” 03/04/15 New York
Top 3 Personal Health Tips From the Founders of Elysium 03/04/15 Boston
Blueprint Cuts $265M Alexion Deal With IPO in Sight 03/03/15 Boston
Focused on Glaucoma, Aerie Looks Toward Unblinding Critical Data 03/03/15 New York
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Paul Maritz Brings Cloud Expertise to Nanobiosym With Investment 02/26/15 Boston
New Harvard i-lab Head Talks Global Expansion, Startup Initiatives 02/26/15 Boston
Innovation Hub: Meet the Science Evangelist 02/20/15 National
WHO Approves 15-Minute Ebola Test Developed by Corgenix 02/20/15 Boulder/Denver
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Page 3 of 94 « previous page · next page »